MedPath

ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Pending
Register Number

14923001IP

Prescription Type

Uso Hospitalario

Authorization Date

Oct 1, 2020

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number14923001IP
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

VEDOLIZUMABActive
Quantity: 300 mg
Name: VEDOLIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AG
L04AG05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.